StockData
VolitionRx Ltd logo

VolitionRx Ltd (VNRX) stock

VNRXNYSEIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 4/30
$0.19−0.01 (-5.56%)

Close on Nov 17, 2026Market cap $2.58MP/E –Yield –

VolitionRx cash

Cash and short-term investments held at the end of each period.

VolitionRx's cash was $2.80M at Jun 30, 2026. For fiscal 2025 it was $1.12M, down 65.8% from the year before. Over ten years it grew -15.4% a year on average. The highest annual figure on record is $21.68M in fiscal 2016.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.12M-65.8%
FY2024Dec 31, 2024$3.26M-84.3%
FY2023Dec 31, 2023$20.73M+90.8%
FY2022Dec 31, 2022$10.87M-47.2%
FY2021Dec 31, 2021$20.58M+5.8%
FY2020Dec 31, 2020$19.44M+14.6%
FY2019Dec 31, 2019$16.97M+26.4%
FY2018Dec 31, 2018$13.43M+32.7%
FY2017Dec 31, 2017$10.12M-53.3%
FY2016Dec 31, 2016$21.68M+266.4%
FY2015Dec 31, 2015$5.92M+176.6%
FY2014Dec 31, 2014$2.14M+140.7%
FY2013Dec 31, 2013$888.70K+136.1%
FY2012Dec 31, 2012$376.42K+8.2%
FY2011Dec 31, 2011$347.89K+632.7%
FY2010Dec 31, 2010$47.48K–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$2.80M+24.1%
Q1 FY2026Mar 31, 2026$3.10M+19.3%
Q4 FY2025Dec 31, 2025$1.12M-65.8%
Q3 FY2025Sep 30, 2025$200.00K-96.3%
Q2 FY2025Jun 30, 2025$2.26M-62.4%
Q1 FY2025Mar 31, 2025$2.60M-77.9%
Q4 FY2024Dec 31, 2024$3.26M-84.3%
Q3 FY2024Sep 30, 2024$5.41M-49.9%
Q2 FY2024Jun 30, 2024$6.00M-69.6%
Q1 FY2024Mar 31, 2024$11.77M+17.6%
Q4 FY2023Dec 31, 2023$20.73M+90.8%
Q3 FY2023Sep 30, 2023$10.81M-34.2%
Q2 FY2023Jun 30, 2023$19.74M+18.0%
Q1 FY2023Mar 31, 2023$10.01M-57.8%
Q4 FY2022Dec 31, 2022$10.87M-47.2%
Q3 FY2022Sep 30, 2022$16.42M-28.3%
Q2 FY2022Jun 30, 2022$16.73M-40.1%
Q1 FY2022Mar 31, 2022$23.73M-28.2%
Q4 FY2021Dec 31, 2021$20.58M+5.8%
Q3 FY2021Sep 30, 2021$22.90M+9.4%
Q2 FY2021Jun 30, 2021$27.91M+31.0%
Q1 FY2021Mar 31, 2021$33.06M+176.2%
Q4 FY2020Dec 31, 2020$19.44M+14.6%
Q3 FY2020Sep 30, 2020$20.93M+6.2%
Q2 FY2020Jun 30, 2020$21.31M+15.1%
Q1 FY2020Mar 31, 2020$11.97M-26.0%
Q4 FY2019Dec 31, 2019$16.97M+26.4%
Q3 FY2019Sep 30, 2019$19.70M+20.3%
Q2 FY2019Jun 30, 2019$18.51M+55.6%
Q1 FY2019Mar 31, 2019$16.17M+13.4%
Q4 FY2018Dec 31, 2018$13.43M+32.7%
Q3 FY2018Sep 30, 2018$16.37M+18.3%
Q2 FY2018Jun 30, 2018$11.89M-27.9%
Q1 FY2018Mar 31, 2018$14.26M-22.8%
Q4 FY2017Dec 31, 2017$10.12M-53.3%
Q3 FY2017Sep 30, 2017$13.84M+10.5%
Q2 FY2017Jun 30, 2017$16.51M–
Q1 FY2017Mar 31, 2017$18.47M–
Q4 FY2016Dec 31, 2016$21.68M–
Q3 FY2016Sep 30, 2016$12.53M–

More VolitionRx figures

See a number that looks wrong?